Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

3 Must-Own Dividend Stocks for Retirees

By Marc Guberti, InvestorPlace Contributor
These dividend stocks for retirees have endured many market cycles and offer more stability than growth stocks.

3 Biotech Stocks With the Strongest Clinical Pipelines

By Ian Cooper, InvestorPlace Contributor
Many industry heavyweights are on the hunt for fresh new ideas -- great news for biotech stocks to buy with strong pipelines.

Investing in the Cannabis Industry: 3 Stocks to Buy Now

By Will Ashworth, InvestorPlace Contributor
Anyone looking for cannabis stocks to buy is most likely an aggressive investor. These three can help you get a rush.

6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%

By Rich Duprey, InvestorPlace Contributor
Wall Street is forever optimistic about the future for stocks and pegs these seven Nasdaq 100 stocks as ready for supersonic growth.

Why Is Durect (DRRX) Stock Down 64% Today?

By William White, InvestorPlace Writer
Durect stock is taking a beating on Wednesday as DRRX investors react to results from a Phase 2b clinical trial of larsucosterol.

Why Is Heart Test Laboratories (HSCS) Stock Up 298% Today?

By William White, InvestorPlace Writer
Heart Test Laboratories stock is rising higher on Tuesday with heavy trading of HSCS despite a lack of news concerning the company.

3 Promising Biotech Stocks Flying Under the Radar

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
Breakthroughs in healthcare are happening everyday, make sure you are keeping up to date on these under the radar biotech stocks.

3 Speculative Stocks for 100% Returns at the Blink of an Eye

By Faisal Humayun, InvestorPlace Contributor
These are the speculative stocks to buy as they represent companies with average fundamentals and impending growth catalysts.

BMRN Stock Jumps 12% as Activist Elliott Targets BioMarin Pharmaceuticals

By Chris MacDonald, InvestorPlace Contributor
Shares of BMRN stock are on the move today as activist investor Elliott Investment Management builds a position in this drugmaker.

Billionaire’s Blueprint: 3 Under-the-Radar Stocks Ready for Massive Growth

By Yiannis Zourmpanos, InvestorPlace Contributor
In this era of sustainability, technological innovation, and diversified markets, three companies have emerged as compelling investment opportunities.

Cannabis Cash Burn Concerns? Sell These 7 Overbought Stocks Now.

By Muslim Farooque, InvestorPlace Contributor
These overbought cannabis stocks are teetring on the edge as the sector is navigating through uncharted waters.

Your Smartest Buys Now: The Top 7 Bargain Stocks to Buy in November

By Yiannis Zourmpanos, InvestorPlace Contributor
Are you looking for the smartest buys in November? Here are the top seven bargain stocks to buy in November.

Why Is TransMedics (TMDX) Stock Up 53% Today?

By William White, InvestorPlace Writer
TransMedics stock is taking off on Tuesday as TMDX investors react to strong revenue and a guidance increase in its Q3 earnings report.

Why Is PaxMedica (PXMD) Stock Up 95% Today?

By William White, InvestorPlace Writer
PaxMedica stock is taking off with heavy trading of PXMD shares following positive results from a Phase 2 clinical trial.

Why Is Ventyx Biosciences (VTYX) Stock Down 76% Today?

By William White, InvestorPlace Writer
Ventyx Biosciences stock is taking a beating on Tuesday after the company announced it will end development of VTX958 on Phase 2 results.

Why Is Tharimmune (THAR) Stock Up 113% Today?

By William White, InvestorPlace Writer
Tharimmune stock is gaining with heavy trading of THAR shares after the company announced an exclusive worldwide licensing agreement.

Why Is Senti Biosciences (SNTI) Stock Up 140% Today?

By William White, InvestorPlace Writer
Senti Biosciences stock is rising higher on Tuesday as SNTI shares see heavy trading on a strategic collaboration announcement.

3 Blue-Chip Stocks With Strong Dividends

By Charles Munyi, InvestorPlace Contributor
Build a reliable income stream with these undervalued blue-chip stocks with dividends that are currently out of favor.

3 Biotech Moonshots to Bet on the Future of Health

By Larry Ramer, InvestorPlace Contributor
Thanks to their potential blockbuster drugs, these three biotech stocks may yield huge returns for patent investors willing to take the risk.
Load More Articles